Genetic susceptibility to breast cancer risk associated with inorganic arsenic exposure
- PMID: 28889078
- DOI: 10.1016/j.etap.2017.08.032
Genetic susceptibility to breast cancer risk associated with inorganic arsenic exposure
Abstract
Objective: To evaluate whether the association between breast cancer (BC) and inorganic arsenic (iAs) exposure is modulated by selected polymorphisms in iAs metabolism.
Methods: A population based case-control (1016/1028) study was conducted in Northern Mexico. Urinary arsenic metabolites were measured by High Performance Liquid Chromatography. Metabolites percentages and methylation ratios, were estimated. Genotypes of selected polymorphisms were determined by allelic discrimination. The interaction between polymorphisms and iAs metabolites percentages and methylation ratios on BC was assessed with unconditional logistic regression models.
Results: A significant interaction (p=0.002) between MTR c.2756A>G polymorphism and percentage dimethylarsinic acid (DMA) on BC was found; BC risk related with %DMA was lower in AG+GG carriers than in AA carriers. No other significant interactions were found.
Conclusion: MTR c.2756A>G polymorphism may confer protection for BC associated with iAs exposure. Further research is warranted to elucidate the potential involvement of other polymorphisms in iAs-related BC.
Keywords: Arsenic metabolism; Breast cancer; Genetic susceptibility; Inorganic arsenic; Polymorphisms.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Arsenic methylation capacity in relation to nutrient intake and genetic polymorphisms in one-carbon metabolism.Environ Res. 2018 Jul;164:18-23. doi: 10.1016/j.envres.2018.01.050. Epub 2018 Feb 17. Environ Res. 2018. PMID: 29459232
-
Arsenic methylation capacity is associated with breast cancer in northern Mexico.Toxicol Appl Pharmacol. 2014 Oct 1;280(1):53-9. doi: 10.1016/j.taap.2014.07.013. Epub 2014 Jul 22. Toxicol Appl Pharmacol. 2014. PMID: 25062773
-
Inorganic arsenic methylation capacity and breast cancer by immunohistochemical subtypes in northern Mexican women.Environ Res. 2020 May;184:109361. doi: 10.1016/j.envres.2020.109361. Epub 2020 Mar 16. Environ Res. 2020. PMID: 32209496
-
AS3MT, GSTO, and PNP polymorphisms: impact on arsenic methylation and implications for disease susceptibility.Environ Res. 2014 Jul;132:156-67. doi: 10.1016/j.envres.2014.03.012. Epub 2014 May 8. Environ Res. 2014. PMID: 24792412 Review.
-
Arsenic metabolism and cancer risk: A meta-analysis.Environ Res. 2017 Jul;156:551-558. doi: 10.1016/j.envres.2017.04.016. Epub 2017 Apr 26. Environ Res. 2017. PMID: 28433864 Review.
Cited by
-
Breast Cancer and Arsenic Anticancer Effects: Systematic Review of the Experimental Data from In Vitro Studies.Biomed Res Int. 2022 Dec 29;2022:8030931. doi: 10.1155/2022/8030931. eCollection 2022. Biomed Res Int. 2022. PMID: 36619302 Free PMC article. Review.
-
Mendelian Randomization and GWAS Meta Analysis Revealed the Risk-Increasing Effect of Schizophrenia on Cancers.Biology (Basel). 2022 Sep 12;11(9):1345. doi: 10.3390/biology11091345. Biology (Basel). 2022. PMID: 36138824 Free PMC article.
-
The possible role of arsenic and gene-arsenic interactions in susceptibility to breast cancer: a systematic review.Rev Environ Health. 2020 Dec 25;36(4):523-534. doi: 10.1515/reveh-2020-0080. Print 2021 Dec 20. Rev Environ Health. 2020. PMID: 34223716 Free PMC article. Review.
-
Arsenic methylation - Lessons from three decades of research.Toxicology. 2021 Jun 15;457:152800. doi: 10.1016/j.tox.2021.152800. Epub 2021 Apr 24. Toxicology. 2021. PMID: 33901604 Free PMC article. Review.
-
Arsenic Exposure and Breast Cancer Risk: A Re-Evaluation of the Literature.Nutrients. 2020 Oct 28;12(11):3305. doi: 10.3390/nu12113305. Nutrients. 2020. PMID: 33126678 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
